Skip To Main Content
Gauthier Bouche on Muck Rack

Gauthier Bouche

Brussels
As seen in: Nature, PLOS, The Lancet, Dove Medical Press, Future Medicine, eCancer, ecancermedicalscience, EJSO - European Journal of Surgical Oncology
Clinical trial = best human invention. Love innovations that use existing things. MD @anticancerfund
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gauthier

Contact Gauthier, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reply to ‘Stimulating medicines repurposing in the EU: a pilot project’

|
By Pan Pantziarka, Patricia Vandamme, Alicia Belda Soler, Gauthier Bouche, Donald C. Lo
| Nature Verified
A recent article by Bouygues and colleagues reported on the European Union (EU) STAMP pilot programme on drug repurposing (Nat. Rev. Drug Discov. 25, 12–13; 2026)1. We thank the authors for offering valuable lessons for the drug repurposing field. The report noted overall lack of involvement by marketing authorization holders (MAHs), which is perhaps not unexpected given the financial disincentives that often limit the commercial repurposing of generic medicines2.
Open in Who Shared Issue with article?

Pancreatic Cancer

|
By Gauthier Bouche, Alexandre Alencar, Evelyn Hewitt, Stephen J Bigelsen
| Dove Medical Press
Back to Journals » Cancer Management and Research » Volume 17 Authors Hewitt E, Bouche G, Alencar AC, Bigelsen SJ , Radu R, Stoyanova-Beninska V , Carrato A , Valsecchi F, Soler Cantón A, van der Meer HG , García Bermejo ML, Budillon A, Cardone L, Rooman I, Platteeuw H, Baijet J, Fuchs C Received 29 August 2024 Accepted for publication 2 February 2025 Published 1 March 2025 Volume 2025:17 Pages 429—440 DOI https://doi.org/10.2147/CMAR.S483151 Checked for plagiarism Yes Review by Single...
Open in Who Shared Issue with article?

Determining the optimal use of approved drugs in oncology

|
By Gauthier Bouche, Duncan C Gilbert, Sophie Merrick
| The Lancet Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Patrono, C Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease Eur Heart J. 2024; 45:2362-2376 2. Amorim, LC ∙ Peixoto, RD Should we still be using bolus 5-FU prior to infusional regimens in gastrointestinal cancers? A practical review Int Cancer Conf J. 2021; 11:2-5 3. Hoog, CJPO ∙ Mehra, N ∙ Maliepaard, M ∙ et al.
Open in Who Shared Issue with article?
See all 21 articles